Arnold Ganser
Arnold Ganser
Professor of Medicine (em) at Hannover Medical School, Germany
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Genomic classification and prognosis in acute myeloid leukemia
E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ...
New England Journal of Medicine 374 (23), 2209-2221, 2016
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
KC Wollert, GP Meyer, J Lotz, SR Lichtenberg, P Lippolt, C Breidenbach, ...
The Lancet 364 (9429), 141-148, 2004
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
RF Schlenk, K Döhner, J Krauter, S Fröhling, A Corbacioglu, L Bullinger, ...
New England Journal of Medicine 358 (18), 1909-1918, 2008
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST …
GP Meyer, KC Wollert, J Lotz, J Steffens, P Lippolt, S Fichtner, H Hecker, ...
Circulation 113 (10), 1287-1294, 2006
Monitoring of bone marrow cell homing into the infarcted human myocardium
M Hofmann, KC Wollert, GP Meyer, A Menke, L Arseniev, B Hertenstein, ...
Circulation 111 (17), 2198-2202, 2005
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
A Engert, A Plütschow, HT Eich, A Lohri, B Dörken, P Borchmann, ...
New England Journal of Medicine 363 (7), 640-652, 2010
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
D Hoelzer, E Thiel, H Loffler, T Büchner, A Ganser, G Heil, P Koch, ...
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
FG Rücker, RF Schlenk, L Bullinger, S Kayser, V Teleanu, H Kett, ...
Blood, The Journal of the American Society of Hematology 119 (9), 2114-2121, 2012
Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final …
M Lübbert, S Suciu, L Baila, BH Rüter, U Platzbecker, A Giagounidis, ...
Journal of clinical oncology 29 (15), 1987-1996, 2011
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, G Mufti, ...
Blood, The Journal of the American Society of Hematology 118 (14), 3765-3776, 2011
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ...
Molecular & cellular proteomics 9 (11), 2424-2437, 2010
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase …
F Ciceri, C Bonini, MTL Stanghellini, A Bondanza, C Traversari, ...
The lancet oncology 10 (5), 489-500, 2009
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
N Gökbuget, M Kneba, T Raff, H Trautmann, CR Bartram, R Arnold, ...
Blood, The Journal of the American Society of Hematology 120 (9), 1868-1876, 2012
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
F Thol, S Kade, C Schlarmann, P Löffeld, M Morgan, J Krauter, ...
Blood, The Journal of the American Society of Hematology 119 (15), 3578-3584, 2012
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
S Kayser, K Doehner, J Krauter, CH Koehne, HA Horst, G Held, ...
Blood, The Journal of the American Society of Hematology 117 (7), 2137-2145, 2011
Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation
AR Choudhury, Z Ju, MW Djojosubroto, A Schienke, A Lechel, ...
Nature genetics 39 (1), 99-105, 2007
Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
J Krönke, RF Schlenk, KO Jensen, F Tschürtz, A Corbacioglu, VI Gaidzik, ...
Journal of Clinical Oncology 29 (19), 2709-2716, 2011
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
L Venturini, K Battmer, M Castoldi, B Schultheis, A Hochhaus, ...
Blood 109 (10), 4399-4405, 2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20